What is Cyramza (ramucirumab)
Cyramza is a cancer medication called a vascular endothelial growth factor (VEGF) Receptor 2 antagonist. It works by blocking the blood supply to tumors.
Company that Manufactures/ Markets:
M/s Eli Lilly
Cyramza is indicated in the treatment of advanced gastric cancer or gastro –oesophageal junction adenocarcinoma, as a single agent after fluoropyrimidine or platinum containing chemotherapy.
For treatment related information, please consult your treating Physician.
Cyramza is supplied at a concentration of 100 mg (10 ml) or 500 mg (50 ml) single dose vials
Storage and handling
Store vials in a refrigerator at 2° to 8° C until time of use. Do not freeze or shake the vial.
How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Contact us @ +91 7678048225 or by email firstname.lastname@example.org.